Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654895 · ClinicalTrials.gov registry record
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
A clinical trial of Sepsis, Septic Shock, sponsored by Bluejay Diagnostics.
- Recruiting
- Registry status
- 700
- Enrollment target
- 5
- Study locations
NCT06654895: Recruiting study of Sepsis, Septic Shock, sponsored by Bluejay Diagnostics.
NCT06654895 is a study of Sepsis, Septic Shock that is actively recruiting participants, run by Bluejay Diagnostics. The registered enrollment target is 700 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06654895, a study of Sepsis, Septic Shock, is actively recruiting participants, sponsored by Bluejay Diagnostics.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
Primary Outcome
Participants will be followed up for 28 days for all-cause mortality
Conditions Studied
Study Locations (5)
Florida
- University of Florida College of Medicine - Gainesville
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
North Carolina
- Wake Forest School of Medicine - Winston-Salem
Tennessee
- Vanderbilt University Medical Center - Nashville
Utah
- Intermountain Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2024-11-12 |
| Est. Completion | 2026-08-30 |
What NCT06654895 shows while recruiting
NCT06654895 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sepsis, Septic Shock appearing as the primary indexed condition, and to 0 interventions.
NCT06654895 lists 5 locations in 5 states (Florida, Massachusetts, North Carolina).
Frequently Asked Questions
What is clinical trial NCT06654895 about?
NCT06654895 is a clinical study titled "Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study". The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
What is the current status of trial NCT06654895?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2024-11-12. Estimated completion is 2026-08-30.
What conditions does trial NCT06654895 study?
This clinical trial studies the following conditions: Sepsis, Septic Shock.
Who is sponsoring clinical trial NCT06654895?
This trial is sponsored by Bluejay Diagnostics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06654895 being conducted?
This trial has 5 study locations across Florida, Massachusetts, North Carolina, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis, Septic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI